Chemical formula: C₃₀H₃₄N₂O₃ Molecular mass: 470.613 g/mol PubChem compound: 154257
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G03XC02 | Bazedoxifene | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03X Other sex hormones and modulators of the genital system → G03XC Selective estrogen receptor modulators |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| CONBRIZA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Bazedoxifene is an active ingredient of these brands:
United States (US)
Brazil (BR)
Canada (CA)
Cyprus (CY)
Finland (FI)
France (FR)
Israel (IL)
Japan (JP)
Mexico (MX)
New Zealand (NZ)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
